Product name: AMADQ
Format: White powder
Description: Peptide AMADQ exhibited analgesic activity in mouse models of persistent neuropathic pain and inflammation. AMADQ also inhibited tumor necrosis factor alpha and cyclooxygenase-2 production. The mitogen-activated protein kinase signaling pathway, which is involved in analgesic and anti-inflammatory functions, was inhibited by AMADQ. Thus, the analgesic and anti-inflammatory effects of these peptides, especially AMADQ, demonstrated their potential as candidates for the development of novel analgesic medicines.
Usage: For Scientific Research Use Only, Not for Human Use.